Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.marketwatch.com/story/neurosense-therapeutics-sees-positive-trial-results-for-tdp-43-alzheimer-s-treatment-271674136994
0
0
NeuroSense Therapeutics Sees Positive Trial Results for TDP-43 Alzheimer's Treatment - MarketWatch
+ 65 more
1/19/23 at 2:03pm
Organization
MarketWatch
Authors
Details
37 words
Summarize
Health
Pharmaceuticals & Biotech
Cancer
NeuroSense Therapeutics Sees Positive Trial Results
TDP-43 Alzheimer's
Chris Wack NeuroSense Therapeutics Ltd.
Treatment - MarketWatch
NeuroSense
By Chris Wack NeuroSense Therapeutics Ltd. said it saw positive final results from a biomarker study conducted to evaluate the potential of NeuroSense's...
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...